✦ LIBER ✦

O-90 Randomised phase III trial of docetaxel/carboplatin vs. MIC/MVP chemotherapy in inoperable advanced non-small cell lung cancer (NSCLC) — A British thoracic oncology group (BTOG) trial

✍ Scribed by Booton, Richard; Ascroft, Linda; Stout, Ron; Lorigan, Paul; Faivre-Finn, Corinne; Thatcher, Nicholas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-43 Randomised phase III trial of docet

✍ Booton, Richard; Campbell, Daniel; Ward, Tim; Ashcroft, L.; Power, Fiona; Taylor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 348 KB

O-095 A phase III trial of docetaxel/car

✍ Lorigan, P. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

22 Costs of cisplatin and carboplatin in

✍ Gaunt, P.; Frew, E.; Jarrett, H.; Billingham, L.; Ferry, D.; Dunlop, D.; Thompso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

O-094 Paclitaxel and gemcitabine vs carb

✍ Kosmidis, P.; Kalofonos, C.; Syrigos, K.; Skarlos, D.; Fountzilas, G.; Nicolaide 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

O-89 S0003: Paclitaxel/carboplatin (PC)

✍ Williamson, Stephen K.; Crowley, John J.; Lara, Primo N.; Tucker, Robert W.; McC 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

O-092 Randomized phase III study of doce

✍ Tamura, K.; Kudoh, S.; Negoro, S.; Nakagawa, K.; Takada, M.; Katakami, N.; Matsu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB